Thermo Fisher Scientific (TMO) won approval from the European Commission to acquire Solventum's (SOLV) purification and filtration business.
The transaction relates primarily to the bioprocessing filtration sector and was approved
under a simplified review process with no competition concerns, the commission said Monday in a statement.
Thermo Fisher shares fell 1.7% in recent trading Monday, and Solventum eased 0.3%.
Price: 427.32, Change: -7.54, Percent Change: -1.74
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.